Leber hereditary optic neuropathy: Do folate pathway gene alterations influence the expression of mitochondrial DNA mutation?

Iranian Journal of Public Health

Volumn 39, Issue 3, 2010, Pages 53-60

  Aleyasin, A ^a   Ghazanfari, M ^a   Houshmand, M ^a  

^a NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

Author keywords

Folic acid; LHON, MTHFR, MTRR, Folate

Indexed keywords

EID: 77958540095     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Leber T (1871). Ueber hereditaere und congenital angelegte Sehnevenleiden. Grae-fes Arch Ophthal, 17: 249-291.
2. Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AM, Elsas LJ, Niko-skelainen EK (1988). Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science, 242(4884): 1427-1430.
3. Mashima Y, Hiida Y, Oguchi Y, Kudoh J, Shimizu N (1993). High frequency of mutations at position 11778 in mitochon-drial ND4 gene in Japanese families with Leber's hereditary optic neuropathy. Hum Genet, 92(1): 101-102.
4. Riordan-Eva P, Sanders MD, Govan GG, Sweeney MG, Da Costa J, Harding AE (1995). The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain, 118(Pt2): 319-337.
5. Chalmers RM, Schapira AH (1999). Clinical, biochemical and molecular genetic features of Leber's hereditary optic neuropathy. Biochim Biophys Acta, 1410(2): 147-158.
6. Howell N, Mackey DA (1998). Low-penetrance branches in matrilineal pedigrees with Leber hereditary optic neuropathy. Am J Hum Genet, 63(4): 1220-1224.
7. Huoponen K (2001). Leber hereditary optic neuropathy: clinical and molecular genetic findings. Neurogenetics, 3(3): 119-125.
8. Mackey D, Howell N (1994). Tobacco amblyopia. Am J Ophthalmol, 117(6): 817-819.
9. Howell N (1997). Leber hereditary optic neuropathy: mitochondrial mutations and degeneration of the optic nerve. Vision Res, 37(24): 3495-3507.
10. Chinnery PF, Andrews RM, Turnbull DM, Howell NN (2001). Leber hereditary optic neuropathy: Does heteroplasmy influence the inheritance and expression of the G11778A mitochondrial DNA mutation? Am J Med Genet, 98(3): 235-243.
11. Sprecher H, Barr HM, Slotky JI, Tzukerman M, Eytan GD, Assaraf YG (1995). Alteration of mitochondrial gene expression and disruption of respiratory function by the lipophilic antifolate pyrimethamine in mammalian cells. J Biol Chem, 270(35): 20668-20676.
12. Parry TE (1994). Folate responsive neuropathy. Presse Med, 23(3): 131-137.
13. Al-Gazali LI, Padmanabhan R, Melnyk S, Yi P, Pogribny IP, Pogribna M, Bakir M, et al. (2001). Abnormal folate metabolism and genetic polymorphism of the folate pathway in a child with Down syndrome and neural tube defect. Am J Med Genet, 103 (2): 128-132.
14. Pietrzik K, Bronstrup A (1997). The role of homocysteine, folate and other B-vitamins in the development of atherosclerosis. Arch Latinoam Nutr, 47(2 Suppl 1): 9-12.
15. Di Pietro E, Sirois J, Tremblay ML, Mac Kenzie RE (2002). Mitochondrial NAD-dependent methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclo-hydrolase is essential for embryonic development. Mol Cell Biol, 22(12): 4158-4166.
16. Leclerc D, Wilson A, Dumas R, Gafuik C, Song D, Watkins D, et al. (1998). Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci USA, 95(6): 3059-3064.
17. Wilson A, Platt R, Wu Q, Leclerc D, Christensen B, Yang H, et al. (1999). A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bi-fida. Mol Genet Metab, 67(4): 317-323.
18. Ou CY, Stevenson RE, Brown VK, Schwartz CE, Allen WP, Khoury MJ, et al. (1996). 5, 10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet, 63 (4): 610-614.
19. Mills JL, Kirke PN, Molloy AM, Burke H, Conley MR, Lee YJ, et al. (1999). Methylenetetrahydrofolate reductase thermolabile variant and oral clefts. Am J Med Genet, 86(1): 71-74.
20. Johns DR, Heher KL, Miller NR, Smith KH (1993). Leber's hereditary optic neuropathy. Clinical manifestations of the 14484 mutation. Arch Ophthalmol, 111(4): 495-498.
21. Ozkul Y, Evereklioglu C, Borlu M, Taheri S, Calis M, Dündar M, et al. (2005). 5, 10-Methylenetetrahydrofolate reductase C677T gene polymorphism in Behcet's patients with or without ocular involvement. Br J Ophthalmol, 89(12): 1634-1637.
22. Johns DR (1990). The molecular genetics of Leber's hereditary optic neuropathy. Arch Ophthalmol, 108 (10): 1405-7.
23. Jun AS, Brown MD, Wallace DC (1994). A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydro-genase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc Natl Acad Sci USA, 91(13): 6206-6210.
24. Friedman G, Goldschmidt N, Friedlander Y, Ben-Yehuda A, Selhub J, Babaey S, et al. (1999). A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr, 129 (9): 1656-1661.
25. Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA, et al. (1999). Polymorphisms in the methylenetetrahy-drofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA, 96 (22): 12810-1285.
26. Chen J, Giovannucci E, Kelsey K, Rimm EB, Stampfer MJ, Colditz GA, Spiegelman D, et al. (1996). A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res, 56(21): 4862-4864.
27. Surtees R, Leonard J, Austin S (1991). Association of demyelination with deficiency of cerebrospinal fluid s-adenosylmethion-ine in inborn errors of methyl-transfer pathway. Lancet, 338 (8782-8783): 1550-1554.